•   
  •   
  •   

Politics Eastman Kodak's $765 million U.S. loan agreement on hold after recent allegations

01:16  09 august  2020
01:16  09 august  2020 Source:   reuters.com

Warren asks SEC about insider trading in Trump’s Kodak pharmaceuticals announcement

  Warren asks SEC about insider trading in Trump’s Kodak pharmaceuticals announcement Shares of Kodak began to soar last week even before President Donald Trump’s announcement that the company was in line for a $765 million government loan to support the manufacture of pharmaceutical ingredients. But, was any of the unusual volume attributable to insider trading? That’s what Sen. Elizabeth Warren wants the Securities and Exchange Commission […] The post Warren asks SEC about insider trading in Trump’s Kodak pharmaceuticals announcement appeared first on Roll Call.

Eastman Kodak Company (KODK). NYSE - NYSE Delayed Price. Eastman Kodak Co.’ s share price rally after news of a $ 765 million government loan to help it make drug ingredients at its U . S . factories has offered shareholders and executives with stock options a tidy windfall.

The Eastman Kodak Company, known for making film and other photography-related products, will receive a $ 765 million loan from the federal government in order to start The federal government wants to stop relying so much on China, India, and other foreign countries for medicine, and the U . S

By Kanishka Singh

a display in a store: FILE PHOTO: A worker cleans a Kodak booth at the Las Vegas Convention Center in preparation for 2019 CES in Las Vegas © Reuters/Steve Marcus FILE PHOTO: A worker cleans a Kodak booth at the Las Vegas Convention Center in preparation for 2019 CES in Las Vegas

(Reuters) - Eastman Kodak Co's $765 million loan agreement with the U.S. government to produce pharmaceutical ingredients has been put on hold due to "recent allegations of wrongdoing," the U.S. International Development Finance Corp (DFC) said.

Earlier this week, senior Democratic lawmakers asked federal regulators to investigate securities transactions made by the company and its executives around the time it learned it could receive the government loan.

'Selling Sunset' Agents' Earnings: Who Has Made the Most?

  'Selling Sunset' Agents' Earnings: Who Has Made the Most? Bringing in the big bucks! Ever since Selling Sunset debuted in 2018, the world was given an inside look at the multi-million dollar homes the Oppenheim Group’s agents sell in Los Angeles. Christine Quinn, Mary Fitzgerald, Davina Potratz, Chrishell Stause, Maya Vander, Amanza Smith and Heather Rae Young work as the main agents on the Netflix series, which follows both their personal lives — including Stause’s divorce from Justin Hartley and Quinn’s over-the-top wedding to Christian Richard — and their lavish careers. Some of the celebrity clients that the Selling Sunset agents have sold to include Ellen DeGeneres, Orlando Bloom and Meryl Streep. But who brings in the most money? When a mansion is sold on the show, the price it is sold for is listed, followed by the commission that the agent seemingly receives. Davina recently gave an example to Evoke.ie in which the agents take home 75 percent of the commission while 25 percent goes to the broker. “The way it works in real estate, there is a broker license and there’s a salesperson license, so the broker is the higher license,” she said in an interview published in 2019. “The salespeople have to work underneath the broker license and the brokers also carry more responsibility, if anything goes wrong or if anyone gets sued the broker is responsible.” Although she didn’t reveal what the Oppenheim Group’s splits with the brokers are, the director of the new development division noted it’s different for each agent.

In recent years, Kodak has made some The Eastman Kodak Company, known for making film and other photography-related products, will receive a $ 765 million loan from the federal government in order to start producing pharmaceutical ingredients.

The Kodak loan , announced July 28, has triggered no shortage of controversy. The former film company would be the first beneficiary of a Trump administration program aimed at bolstering U . S . drug-making capabilities amid the coronavirus outbreak, despite its lack of a track record in

"Recent allegations of wrongdoing raise serious concerns," DFC said late on Friday in a tweet.

"We will not proceed any further unless these allegations are cleared," the DFC said. It was referring to a letter of interest it signed on July 28 with Kodak.

President Donald Trump on Tuesday said the government would investigate the circumstances surrounding the announcement of the loan, which will help the photographic equipment maker shift into making pharmaceuticals at its U.S. factories.

Kodak shares surged more than 1,000% last week after the loan was announced, generating a windfall for executives, some of whom had received options one day earlier.

Lawmakers said they had "serious concerns" about the transactions and asked the Securities and Exchange Commission to investigate the circumstances surrounding the matter. They cited growing concerns about insider trading.

The company said it had appointed a special committee of independent directors of its board to conduct an internal review.

"The internal review will be conducted for the Committee by Akin Gump Strauss Hauer & Feld LLP," Eastman Kodak said in a statement.

(Reporting by Kanishka Singh in Bengaluru; Editing by Sonya Hepinstall)

'You can't fix stupid' — Trump trade adviser Peter Navarro rips Kodak executives .
"What happened at Kodak was probably the dumbest decisions made by executives in corporate history,” Navarro said.“Based on what I’m seeing, what happened at Kodak was probably the dumbest decisions made by executives in corporate history,” Navarro said on CNBC’s “Squawk Box.

usr: 0
This is interesting!